Posts

NEWS WORTH SHARING - JULY '18

Image
Here are a few things we thought worth sharing this month… Diabetes…Do you want to be part of our plan to develop a leading primary care service? Within the Spirit family of companies we run GP practices.  We recently held an Improving Market Access Meeting with experts in diabetes to consider the problems facing primary care.  As a result of this we plan to make the world for people living with diabetes a healthier and happier place by developing the best possible primary care service we can .  Click here to find out more about the problems we uncovered, the solutions we identified and how you can get involved.  If you would like to find out more, or get involved please let me know. How can I add value? One of the biggest challenges our pharma clients face is how to show the value of their brands to the NHS.  Since joining the Spirit family of companies we have held several Improving Market Access Meetings where we have brought together experts in a particu

JOURNAL OF mHEALTH - Spirit Digital Announced as Cloud-Software Provider on G-Cloud 10

Image

HEALTH SERVICE JOURNAL - Standardisation of medicine doses enhances safety

Image

PRACTICE BUSINESS - Improving access; supporting patient care of type 2 diabetes

Image

WE NEED YOU...TO HELP US DEVELOP AND DELIVER THE BEST COMMUNITY DIABETES SERVICE IN THE WORLD

Image
Within the Spirit family of companies we recently took over the running of a group of GP Practices in Leicester and we are looking to do things differently.  We care for over 1,200 people with diabetes and this number is increasing rapidly. The Challenges as we see them: Diabetes is a growing challenge and all practices are under pressure Sub optimal blood glucose control is common within practice populations and this puts additional pressure on NHS resources Compliance within care pathways and treatment plans is often problematic, in fact some people simply don’t turn up for review  At the moment we have very limited access to diabetes experts within our practices. This leads to variation in the patient pathway. The experience to start Insulin and GLP1’s is rare in primary care  Many people with pre-diabetes are not being identified and are therefore going on to develop full diabetes Many people with existing diabetes have not benefitted from structured diabetes educatio

WHAT IS SIMULATION AND IS IT REALLY WORTH IT?

Image
Are you looking to: Make cost effective decisions in healthcare? Gain ownership of a complex process and communicate this to others? Understand the impact of changes in a risk free environment? …then simulation could be your solution. The NHS is under increasing pressure to deal with rising demand with no immediate increase in funding.  To meet this challenge commissioners, service leads and NHS suppliers need to show how services, products and processes can be improved to provide better value for money.  Advanced statistical analytical tools such as demand forecasting, STAR efficiency frontiers, sophisticated data analysis, simulation and modelling are increasingly being used to do this.  How can simulation and modelling be used to improve healthcare services? What is the difference between a model and a simulation? Models are physical or digital products that represent systems. They are similar to, but usually simpler, than the systems they represent, but retain th

5 REASONS WHY WORKING WITH NHS DATA IS GOOD FOR YOUR BUSINESS

Image
The NHS is data rich, in fact many countries look at the UK with envious eyes when it comes to the volume and quality of our data. But how can using this data with your NHS customers make good business sense? Reason 1 – Because the NHS don’t have time to do it! According to the Office for National Statistics the NHS has a managerial workforce that is one-third the size of that across the UK economy as a whole, so despite the fact that there is a wealth of information available, NHS managers simply don’t have time to pick through and make sense of it.   Reason 2 – To build stronger relationships with your customers This presents an opportunity for pharma companies to become integral to the commissioning process.   It enables pharma companies to highlight where savings and efficiencies can be made.   By working with the NHS to understand the issues they face, pharma companies can build meaningful relationships with the NHS and demonstrate how their products can help to so